Metformin for cancer prevention: a reason for optimism

[...]the results establish the anti-neoplastic efficacy of metformin in non-diabetic patients, refuting the notion that the association of metformin with lower cancer risk recorded in patients with diabetes is merely due to improved disease control.

Saved in:
Bibliographic Details
Published in:The lancet oncology 2016-04, Vol.17 (4), p.407-409
Main Author: Chan, Andrew T
Format: Article
Language:English
Subjects:
Biomarkers
Colorectal cancer
Diabetes
Disease prevention
Hematology, Oncology and Palliative Medicine
Insulin
Insulin resistance
Kinases
Obesity
Studies
Tumors
Citations: Items that this one cites
Items that cite this one
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
Description
Summary:[...]the results establish the anti-neoplastic efficacy of metformin in non-diabetic patients, refuting the notion that the association of metformin with lower cancer risk recorded in patients with diabetes is merely due to improved disease control.
ISSN:1470-2045
1474-5488
DOI:10.1016/S1470-2045(16)00006-1